HR Execs on the Move

BZAM Cannabis

www.bzamheadquarters.com

 
Headquartered in Vancouver, BC, BZAM Cannabis is a multi-licensed Canadian cannabis producer focused on branded consumer goods, cultivation, processing and people.
  • Number of Employees: 250-1000
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details
Seth Mitchell
Director and Head of People and Culture Profile

Similar Companies

Atritech

Atritech is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

CAMH Centre for Addiction and Mental Health

CAMH Centre for Addiction and Mental Health is one of the leading companies in Healthcare, Pharmaceuticals, & Biotech industry. CAMH Centre for Addiction and Mental Health is based in Toronto, ON. You can find more information on CAMH Centre for Addiction and Mental Health at www.camh.net

Riverland Medical Center

Riverland Medical Center is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Ferriday, LA. To find more information about Riverland Medical Center, please visit www.riverlandmedical.com

RemedyMD

RemedyMD is the leading provider of registries for life sciences. RemedyMDs highly specific patient and disease registry software and comparative effectiveness research tools enable researchers, clinicians and scientists to collect, aggregate, harmonize, and analyze data from widely disparate sources and then use RemedyMD tools and applications to identify patterns that result in accelerated discoveries, better patient outcomes, and advance translational research.

StemCells

StemCells, Inc., a biopharmaceutical company, engages in the research, development, and commercialization of cell-based therapeutics and tools for use in stem cell-based research and drug discovery primarily in the United States. Its lead therapeutic product candidate, HuCNS-SC cells (purified human neural stem cells), is in development as a potential treatment for a range of central nervous system disorders. The company has conducted a Phase I clinical trial in Pelizaeus-Merzbacher disease, a fatal myelination disorder in children. It is also conducting a Phase I/II clinical trial in chronic spinal cord injury; and has initiated a Phase I/II clinical trial in dry age-related macular degeneration, as well as is pursuing preclinical studies in Alzheimer’s disease. In addition, the company markets a rage of proprietary cell culture products, research grade human cells, and antibody reagents under the SC Proven brand. The proprietary cell culture products include iSTEM, GS1-R, GS2-M, RHB-A, RHB-Basal, NDiff227, NDiff N2, and NDiff N27 supplements, as well as HEScGRO and ESGRO Complete; and antibody reagents comprise STEM24, STEM101, STEM121, and STEM123, which can be used for cell detection, isolation, and characterization. Further, StemCells is involved in developing and commercializing applications of its technologies to enable stem cell-based research. The company sells its tools and technologies products to researchers at academic institutions, pharmaceutical and biotechnology companies, and government laboratories. StemCells, Inc. was founded in 1988 and is headquartered in Newark, California.